HIGHER CTX-M, TEM, AND SHV EXTENDED-SPECTRUM BETA-LACTAMASE PLASMID GENE COMBINATION FREQUENCY IN ESBL PRODUCING KLEBSIELLA PNEUMONIAE COMPARED WITH ESBL PRODUCING ESCHERICHIA COLI
Abstract
Introduction:Extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae confer antibiotic resistance to broad-spectrum penicillins, cephalosporins, using ESBL genes CTX-M, TEM, SHV, which are encoded in bacterial plasmid genome.
Methods: We compared plasmid CTX-M, TEM, and SHV ESBL gene combinations in ESBL producing Escherichia coliand Klebsiella pneumoniae. Altogether, 136 ESBL producing Enterobacteriaceae isolation cases were analyzed.
Results:The ESBL producing Enterobacteriaceae, mostly K. pneumoniae (n = 66; 48.53%), E. coli (n = 36; 26.47%), were isolated from 52 (38.2%) female and 84 (61.8%) male patients from Riga East Clinical University Hospital. Overall,132 isolates (97.06%) registered positive for the plasmid CTX-M gene, 97 isolates (71.32%) for the plasmid TEM gene, and 87 isolates (63.97%) for the plasmid SHV gene.Patients with the three ESBL plasmid gene (CTX-M+ TEM+ SHV+) combination were significantly older (67.11 ± 14.16 years) than patients with other gene combinations (59.63 ± 18.14 years; p = 0.047). Plasmid SHV gene frequency was higher in K. pneumoniae (p < 0.001). The K. pneumoniae mostly presented with the three plasmid ESBL gene (CTX-M+ TEM+ SHV+) combination, whereas E. coli presented with other gene combinations (p = 0.014).
Conclusions: Klebsiella Pneumoniae, more often, presented with the plasmid SHV ESBL gene and the three ESBL gene (CTX-M+ TEM+ SHV+) combination, compared to E. coli. Older patients with ESBL producing Enterobacteriaceae infection, more often, presented with the three ESBL gene (CTX-M+ TEM+ SHV+) combination, compared to younger patients with the infection.
References
Alekshun, M. N., & Levy, S. B. (2007). Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell, 128(6), 1037–1050. http://doi.org/10.1016/j.cell.2007.03.004
Cantón, R., Novais, a., Valverde, a., Machado, E., Peixe, L., Baquero, F., & Coque, T. M. (2008). Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clinical Microbiology and Infection, 14(SUPPL. 1), 144–153. http://doi.org/10.1111/j.1469-0691.2007.01850.x
Coque, T. M., Baquero, F., & Canton, R. (2008). Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveillance : Bulletin Europ??en Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 13(47), 1–11. http://doi.org/10.1128/AAC.49.7.2693-2700.2005
Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., & Stratchounski, L. (2003). Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals. Antimicrobial Agents and Chemotherapy, 47(12), 3724–3732. http://doi.org/10.1128/AAC.47.12.3724-3732.2003
EUCAST: Resistance mechanisms (2015). Retrieved December 20, 2015, from http://www.eucast.org/resistance_mechanisms/
Hayakawa, K., Gattu, S., Marchaim, D., Bhargava, A., Palla, M., Alshabani, K., & Kaye, K. S. (2013). Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. Antimicrobial Agents and Chemotherapy, 57(8), 4010–8. http://doi.org/10.1128/AAC.02516-12
Kargar, M., Kargar, M., Jahromi, M. Z., Najafi, A., & Ghorbani-Dalini, S. (2014). Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections. Indian Journal of Pathology & Microbiology, 57(2), 244–8. http://doi.org/10.4103/0377-4929.134688
Kassakian, S. Z., & Mermel, L. a. (2014). Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria. Antimicrobial Resistance and Infection Control, 3(1), 9. http://doi.org/10.1186/2047-2994-3-9
Kolar, M., Latal, T., Cermak, P., Bartonikova, N., Chmelarova, E., Sauer, P., & Kesselova, M. (2006). Prevalence of extended-spectrum ??-lactamase-positive Klebsiella pneumoniae isolates in the Czech Republic. International Journal of Antimicrobial Agents, 28(1), 49–53. http://doi.org/10.1016/j.ijantimicag.2006.02.012
Lee, J. H., Bae, I. K., & Lee, S. H. (2012). New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance. Medicinal Research Reviews, 32(1), 216–32. http://doi.org/10.1002/med.20210
Lillo, J., Pai, K., Balode, A., Makarova, M., Huik, K., Kõljalg, S., & Sepp, E. (2014). Differences in Extended-Spectrum Beta-Lactamase Producing Escherichia coli Virulence Factor Genes in the Baltic Sea Region, 2014.
Lin, C. F., Hsu, S. K., Chen, C. H., Huang, J. R., & Lo, H. H. (2010). Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. Journal of Medical Microbiology, 59(Pt 6), 665–71. http://doi.org/10.1099/jmm.0.015818-0
Manoharan, A., Premalatha, K., Chatterjee, S., & Mathai, D. (2011). Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian Journal of Medical Microbiology, 29(2), 161–4. http://doi.org/10.4103/0255-0857.81799
Mehrgan, H., & Rahbar, M. (2008). Prevalence of extended-spectrum ??-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. International Journal of Antimicrobial Agents, 31(2), 147–151. http://doi.org/10.1016/j.ijantimicag.2007.09.008
Mengistu, A., Gaeseb, J., Uaaka, G., Ndjavera, C., Kambyambya, K., Indongo, L., & Sagwa, E. (2013). Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis. Journal of Pharmaceutical Policy and Practice, 6, 4. http://doi.org/10.1186/2052-3211-6-4
Moor, C. T., Roberts, S. A., Simmons, G., Briggs, S., Morris, A. J., Smith, J., & Heffernan, H. (2008). Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. The Journal of Hospital Infection, 68(4), 355–62. http://doi.org/10.1016/j.jhin.2008.02.003
Paterson, D. L., & Bonomo, R. A. (2005). Extended-Spectrum -Lactamases: a Clinical Update. Clinical Microbiology Reviews, 18(4), 657–686. http://doi.org/10.1128/CMR.18.4.657-686.2005
Peralta, G., Lamelo, M., Alvarez-García, P., Velasco, M., Delgado, A., Horcajada, J. P., & Capdevila, J. A. (2012). Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infectious Diseases, 12(1), 245. http://doi.org/10.1186/1471-2334-12-245
Poirel, L., Naas, T., & Nordmann, P. (2008). Genetic support of extended-spectrum ??-lactamases. Clinical Microbiology and Infection, 14(SUPPL. 1), 75–81. http://doi.org/10.1111/j.1469-0691.2007.01865.x
Ruiz de Alegría, C., Rodríguez-Baño, J., Cano, M. E., Hernández-Bello, J. R., Calvo, J., Román, E., & Martínez-Martínez, L. (2011). Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features. Journal of Clinical Microbiology, 49(3), 1134–6. http://doi.org/10.1128/JCM.02514-10
Sasirekha, B. (2013). Prevalence of ESBL, AmpC β-lactamases and MRSA among uropathogens and its antibiogram. Retrieved from http://eldorado.tu-dortmund.de/handle/2003/30327
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015). Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi Journal of Biological Sciences, 22(1), 90–101. http://doi.org/10.1016/j.sjbs.2014.08.002
Spadafino, J. T., Cohen, B., Liu, J., & Larson, E. (2014). Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections. Antimicrobial Resistance and Infection Control, 3(1), 2012–2015. http://doi.org/10.1186/s13756-014-0039-y
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., & Cookson, B. (2014). ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 20 Suppl 1, 1–55. http://doi.org/10.1111/1469-0691.12427
Takaba, K., Shigemura, K., Osawa, K., Nomi, M., Fujisawa, M., & Arakawa, S. (2014). Emergence of extended-spectrum ??-lactamase-producing Escherichia coli in catheter-associated urinary tract infection in neurogenic bladder patients. American Journal of Infection Control, 42(3), e29–e31. http://doi.org/10.1016/j.ajic.2013.11.018
Talukdar, P. K., Rahman, M., Rahman, M., Nabi, A., Islam, Z., Hoque, M. M., & Islam, M. A. (2013). Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PloS One, 8(4), e61090. http://doi.org/10.1371/journal.pone.0061090
The New β-Lactamases - NEJM. (2015). Retrieved June 4, 2015, from http://www.nejm.org/doi/full/10.1056/NEJMra041359
Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., & Spanu, T. (2007). Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrobial Agents and Chemotherapy, 51(6), 1987–94. http://doi.org/10.1128/AAC.01509-06
Wu, T. L., Siu, L. K., Su, L. H., Lauderdale, T. L., Lin, F. M., Leu, H. S., & Ho, M. (2001). Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. The Journal of Antimicrobial Chemotherapy, 47(6), 755–61. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1138910
Copyright information
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (Creative Commons Attribution License 3.0 - CC BY 3.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
info@iseic.cz, www.iseic.cz, ojs.journals.cz
